The anti-inflammatory drugs diclofenac and ketorolac inhibit urease activity and biofilm formation by uropathogenic Proteus mirabilis
Status Publisher Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články
PubMed
40976822
DOI
10.1007/s12223-025-01336-7
PII: 10.1007/s12223-025-01336-7
Knihovny.cz E-zdroje
- Klíčová slova
- Proteus mirabilis, CAUTI, Chelation, Diclofenac sodium, Ketorolac tromethamine, Urease inhibition,
- Publikační typ
- časopisecké články MeSH
Proteus mirabilis is a major bacterium responsible for catheter-associated urinary tract infections (CAUTIs). Urease enzyme has a great role in the pathogenesis of Proteus mirabilis. Using urease, Proteus mirabilis can decompose urea to produce ammonia that increases urine pH and enhances crystal precipitation and crystalline biofilm formation. This leads to catheter blockage and pyelonephritis, respectively. Urease inhibitors are of great value in controlling this problem. Diclofenac sodium and ketorolac tromethamine, with their metal chelating activities, can inactivate urease by chelation of nickel ion in the active site of urease. This study investigated the ability of diclofenac sodium and ketorolac tromethamine to inhibit urease activity in Proteus mirabilis and crystalline biofilm formation. Diclofenac sodium and ketorolac tromethamine showed comparable activities against urease in cell lysates and whole cultures, with subsequent inhibition of pH increase and crystal formation in artificial urine. Diclofenac sodium showed higher biofilm inhibition and downregulation of urease genes ureR and ureC in RT-qPCR. The docking study showed the ability of both drugs to bind to urease enzyme and to chelate nickel ions in the active site of urease, suggesting that nickel chelation is the mode of inhibition of urease enzyme. In conclusion, diclofenac sodium and ketorolac tromethamine are two urease inhibitors that may be useful in treating Proteus mirabilis CAUTI.
Department of Medicinal Chemistry Faculty of Pharmacy Zagazig University Zagazig 44519 Egypt
Department of Microbiology and Immunology Faculty of Pharmacy Zagazig University Zagazig 44519 Egypt
Department of Microbiology Faculty of Veterinary Medicine Zagazig University Zagazig 44519 Egypt
Zobrazit více v PubMed
Abbas HA (2015) Inhibition of virulence factors of Pseudomonas aeruginosa by diclofenac sodium. Roum Arch Microbiol Immunol 74(3–4):79–85 PubMed
Abbas HA, Hegazy WAH (2020) Repurposing anti-diabetic drug “sitagliptin” as a novel virulence attenuating agent in Serratia marcescens. PLoS ONE 15(4):e0231625. https://doi.org/10.1371/journal.pone.0231625 PubMed DOI PMC
Abbas HA, Atallah H, El-Sayed MA, El-Ganiny AM (2020) Diclofenac mitigates virulence of multidrug-resistant Staphylococcus aureus. Arch Microbiol 202(10):2751–2760. 10.1007/s00203-020-01992-y
Abdel-Baky RM, Ali MA, Abuo-Rahma GEDAA, AbdelAziz N (2017) Inhibition of urease enzyme production and some other virulence factors expression in Proteus mirabilis by N-acetyl cysteine and dipropyl disulphide. In: Donelli, G. (eds) Advances in Microbiology, Infectious Diseases and Public Health. Advances in Experimental Medicine and Biology, vol 973. Springer, Cham. https://doi.org/10.1007/5584_2016_197
Al-Harthi HF, Eldrehmy EH, Afaf E, El-Hamid MIA (2024) Antimicrobial resistance and virulence genes profiles of Staphylococcus aureus in meat and meat products. Adv. Anim. Vet. Sci 12(7): 1290–1300. 10.17582/journal.aavs/204/12.7.1290.1300
Alomari M, Taha M, Imran S, Jamil W, Selvaraj M, Uddin N, Rahim F (2019) Design, synthesis, in vitro evaluation, molecular docking and ADME properties studies of hybrid bis-coumarin with thiadiazole as a new inhibitor of Urease. Bioorg Chem 92:103235. https://doi.org/10.1016/j.bioorg.2019.103235 PubMed DOI
Armbruster CE, Prenovost K, Mobley HL, Mody L (2017) How often do clinically diagnosed catheter-associated urinary tract infections in nursing homes meet standardized criteria? J Am Geriatr Soc 65(2):395–401. https://doi.org/10.1111/jgs.14533 PubMed DOI
Armbruster CE, Mobley HL, Pearson MM (2018) Pathogenesis of Proteus mirabilis infection. EcoSal Plus 8(1):10–1128. https://doi.org/10.1128/ecosalplus.ESP-0009-2017 DOI PMC
Askoura M, Saleh M, Abbas H (2020) An innovative role for tenoxicam as a quorum sensing inhibitor in Pseudomonas aeruginosa. Arch Microbiol 202:555–565. https://doi.org/10.1007/s00203-019-01771-4 PubMed DOI
Costerton JW (1999) Introduction to biofilm. Int J Antimicrob Agents 11:217–221 PubMed DOI
Durgadevi R, Veera Ravi A, Alexpandi R, Krishnan Swetha T, Abirami G, Vishnu S, Karutha Pandian S (2019) Virulence targeted inhibitory effect of linalool against the exclusive uropathogen Proteus mirabilis. Biofouling 35(5):508–525. 10.1080/08927014.2019.1619704
Gendlina I, Gutman DM, Thomas V, Collins CM (2002) Urea-dependent signal transduction by the virulence regulator UreR. J Biol Chem 277:37349–37358 PubMed DOI
Hooton TM, Bradley SF, Cardenas DD, Colgan R, Geerlings SE, Rice JC, Saint S,Schaeffer AJ, Tambayh PA, Tenke P, Nicolle LE (2010) Clin Infect Dis 10:321–324. 10.1086/650482
Hu LT, Mobley HLT (1990) Purification and N-terminal analysis of urease from Helicobacter pylori. Infect Immun 58:992–998 PubMed DOI PMC
Jacobsen SM, Shirtliff ME (2011) Proteus mirabilis biofilms and catheter-associated urinary tract infections. Virulence 2:460–465 PubMed DOI
Kafe FN, Abdullah EM, Selman IA (2023) Isolation and detection of UreC and UreR of Proteus mirabilis in gastrointestinal samples from patients with Crohn’s disease in Iraq. JPMS 12(4):37–42 DOI
Khan I, Khan A, Halim SA, Saeed A, Mehsud S, Csuk R, Al-Harrasi A, Ibrar A (2020) Exploring biological efficacy of coumarin clubbed thiazolo [3, 2–b][1, 2, 4] triazoles as efficient inhibitors of urease: a biochemical and in silico approach. Int J Biol Macromol 142:345–354 PubMed DOI
Koch AL (1970) Turbidity measurements of bacterial cultures in some available commercial instruments. Anal Biochem 38(1):252–259 PubMed DOI
Kovala-Demertzi D, Hadjikakou SK, Demertzis MA, Deligiannakis Y (1998) Metal ion–drug interactions. Preparation and properties of manganese (II), cobalt (II) and nickel (II) complexes of diclofenac with potentially interesting anti-inflammatory activity: behavior in the oxidation of 3, 5-di-tert-butyl-o-catechol. J Inorg Biochem 69(4):223–229. https://doi.org/10.1016/S0162-0134(97)10024-1 DOI
Krajewska B (2009) Ureases I. Functional, catalytic and kinetic properties: a review. J Mol Catal B Enzym 59(1–3):9–21 DOI
Li X, Zhao H, Lockatell CV, Drachenberg CB, Johnson DE, Mobley HLT (2002). Visualization of Proteus mirabilis within the matrix of urease-induced bladder stones during experimental urinary tract infection. Infect Immun 70:389–394. 10.1128/IAI.70.1.389-394.2002.
Liu H, Wang Y, Lv M, Luo Y, Liu BM, Huang Y, Wang M, Wang J (2020) Flavonoid analogues as urease inhibitors: synthesis, biological evaluation, molecular docking studies and in-silico ADME evaluation. Bioorg Chem 105:104370. 10.1016/j.bioorg.2020.104370
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25:402–408 PubMed DOI
Milo S, Heylen RA, Glancy J, Williams GT, Patenall BL, Hathaway HJ, Thet NT, Allinson SL, Laabei M, Jenkins ATA (2021) A small-molecular inhibitor against Proteus mirabilis urease to treat catheter-associated urinary tract infections. Sci Rep 11(1):3726. 10.1038/s41598-021-83257-2
Mobley HLT (2019) Proteus mirabilis overview. Methods Mol Biol 2021:1–4. 10.1007/978-1-4939-9601-8_1
Mobley HL, Island MD, Hausinger RP (1995) Molecular biology of microbial ureases. Microbiol Rev 59:451–480 PubMed DOI PMC
Modolo LV, de Souza AX, Horta LP, Araujo DP, de Fatima A (2015) An overview on the potential of natural products as ureases inhibitors: a review. J Adv Res 6(1):35–44. 10.1016/j.jare.2014.09.001
Nakamura H, Yoshiyama H, Takeuchi H et al (1998) Urease plays an important role in the chemotactic motility of Helicobacter pylori in a viscous environment. Infect Immun 66:4832 PubMed DOI PMC
Nicolle LE (2014) Catheter associated urinary tract infections. Antimicrob Resist Infect Control 3:23. 10.1186/2047-2994-3-23
Niël-Weise BS, van den Broek PJ (2005) Urinary catheter policies for short-term bladder drainage in adults. Cochrane Database Syst Rev 3:CD004203.10.1002/14651858.CD004203.pub2. Update in: (2015). Cochrane Database Syst Rev 12:CD004203
Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE (2004) UCSF chimera–a visualization system for exploratory research and analysis. J Comput Chem 25(13):1605–1612 PubMed DOI
Poore CA, Coker C, Dattelbaum JD, Mobley HL (2001) Identification of the domains of UreR, an AraC-like transcriptional regulator of the urease gene cluster in Proteus mirabilis. J Bacteriol 183(15):4526–4535 PubMed DOI PMC
Refat MS, Mohamed GG, Ibrahim MYS, Killa HMA, Fetooh H (2013) Synthesis and characterization of coordination behavior of diclofenac sodium drug toward Hg(II), Pb(II), and Sn(II) metal ions: chelation effect on their thermal stability and biological activity. Synth React Inorg, Met-Org, Nano-Met Chem 44(2):161–170. https://doi.org/10.1080/15533174.2012.752009 DOI
Rokita E, Makristathis A, Presterl E et al (1998) Helicobacter pylori urease significantly reduces opsonization by human complement. J Infect Dis 178:1521–1525 PubMed DOI
Schaffer JN, Pearson MM (2015) Proteus mirabilis and urinary tract infections. Microbiol Spectr. https://doi.org/10.1128/microbiolspec.UTI-0017-2013 PubMed DOI
Schaffer JN, Norsworthy AN, Sun TT, Pearson MM (2016) Proteus mirabilis fimbriae- and urease-dependent clusters assemble in an extracellular niche to initiate bladder stone formation. Proc Natl Acad Sci U S A 113(16):4494–4499. https://doi.org/10.1073/pnas.1601720113 PubMed DOI PMC
Sekar A, Gil D, Tierney P, McCanne M, Daesety V, Trendafilova D, Muratoglu OK, Oral E (2024) Synergistic use of anti-inflammatory ketorolac and gentamicin to target staphylococcal biofilms. J Transl Med 22(1):102. 10.1186/s12967-024-04871-y
Stepanovic S, Vukovic D, Dakic I, Savic B, Svabic-Vlahovic M (2000) A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J Microbiol Methods 40(2):175–179. https://doi.org/10.1016/s0167-7012(00)00122-6 PubMed DOI
Stickler DJ (2014) Clinical complications of urinary catheters caused by crystalline biofilms: something needs to be done. J Intern Med 276(2):120–129. 10.1111/joim.12220
Stickler DJ, Feneley RCL (2010) The encrustation and blockage of long-term indwelling bladder catheters: a way forward in prevention and control. Spinal Cord 48(11):784–790. 10.1038/sc.2010.32
Svane S, Sigurdarson JJ, Finkenwirth F, Eitinger T, Karring H (2020) Inhibition of urease activity by different compounds provides insight into the modulation and association of bacterial nickel import and ureolysis. Sci Rep 10(1):8503. 10.1038/s41598-020-65107-9
Taha M, Rahim F, Khan AA, Anouar EH, Ahmed N, Shah SAA, Ibrahim M, Zakari ZA (2020) Synthesis of diindolylmethane (DIM) bearing thiadiazole derivatives as a potent urease inhibitor. Sci Rep 10:7969 PubMed DOI PMC
Tanaka T, Kawase M, Tani S (2003) Urease inhibitory activity of simple alpha, beta-unsaturated ketones. Life Sci 73(23):2985–2990. https://doi.org/10.1016/s0024-3205(03)00708-2 PubMed DOI
Thomas VJ, Collins CM (1999) Identification of UreR binding sites in the Enterobacteriaceae plasmid-encoded and Proteus mirabilis urease gene operons. Mol Microbiol 31(5):1417–1428 PubMed DOI
Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31(2):455–61. 10.1002/jcc.21334. http://europepmc.org/abstract/MED/19499576
Wasfi R, Hamed SM, Amer MA, Fahmy LI (2020) Proteus mirabilis biofilm: development and therapeutic strategies. Front Cell Infect Microbiol 10:414 PubMed DOI PMC
Wayne P (2011) Clinical and laboratory standards institute. Performance standards for antimicrobial susceptibility testing. Inform Suppl 31(1):100–121
Yang A, Tian Y, Li X (2024) Unveiling the hidden arsenal: new insights into Proteus mirabilis virulence in UTIs. Front Cell Infect Microbiol 14:1465460 PubMed DOI PMC
Yener I, Kocakaya SO, Ertas A, Erhan B, Kaplaner E, Oral EV, Yilmaz-Ozden T, Yilmaz MA, Ozturk M, Kolak U (2020) Selective in vitro and in silico enzymes inhibitory activities of phenolic acids and flavonoids of food plants: relations with oxidative stress. Food Chem 327:127045. https://doi.org/10.1016/j.foodchem.2020.127045 PubMed DOI
Zhang W, Niu Z, Yin K, Liu P, Chen L (2013) Quick identification and quantification of Proteus mirabilis by polymerase chain reaction (PCR) assays. Ann Microbiol 63:683–689. https://doi.org/10.1007/s13213-012-0520-x DOI